메뉴 건너뛰기




Volumn 49, Issue 10, 2004, Pages 1654-1656

Case report: RCAS1, a useful serum marker to predict the recurrence of cancer: Two cases of cholangiocarcinoma and pancreatic cancer

Author keywords

cholangiocarcinoma; pancreatic cancer; RCAS1; tumor marker

Indexed keywords

BIOLOGICAL MARKER; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; MEMBRANE PROTEIN; PROTEIN RCAS 1; UNCLASSIFIED DRUG; EBAG9 PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

EID: 5044221870     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000043381.87424.c3     Document Type: Article
Times cited : (8)

References (13)
  • 1
    • 0032779988 scopus 로고    scopus 로고
    • Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigenRCAS1
    • Nakashima M, Sonoda K, Watanabe T: Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigenRCAS1. Nature Med 5:938-942, 1999
    • (1999) Nature Med , vol.5 , pp. 938-942
    • Nakashima, M.1    Sonoda, K.2    Watanabe, T.3
  • 2
    • 0029966641 scopus 로고    scopus 로고
    • A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas
    • Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T: A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer 77:1501-1509, 1996
    • (1996) Cancer , vol.77 , pp. 1501-1509
    • Sonoda, K.1    Nakashima, M.2    Kaku, T.3    Kamura, T.4    Nakano, H.5    Watanabe, T.6
  • 3
    • 0031747728 scopus 로고    scopus 로고
    • Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias
    • Sonoda K, Kaku T, Kamura T, Nakashima M, Watanabe T, Nakano H: Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias. Clin Cancer Res 4:1517-1520, 1998
    • (1998) Clin Cancer Res , vol.4 , pp. 1517-1520
    • Sonoda, K.1    Kaku, T.2    Kamura, T.3    Nakashima, M.4    Watanabe, T.5    Nakano, H.6
  • 7
    • 0023895365 scopus 로고
    • Tumor markers carbohydrate antigens CA19-9 and CA50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract
    • Harmenberg U, Wahren B, Wiechel KL: Tumor markers carbohydrate antigens CA19-9 and CA50 and carcinoembryonic antigen in pancreatic cancer and benign diseases of the pancreatobiliary tract. Cancer Res 48:1985-1988, 1988
    • (1988) Cancer Res , vol.48 , pp. 1985-1988
    • Harmenberg, U.1    Wahren, B.2    Wiechel, K.L.3
  • 9
    • 0025307965 scopus 로고
    • The clinical utility of the CA19-9 tumor-associated antigen
    • Steinberg W: The clinical utility of the CA19-9 tumor-associated antigen. Am J Gastroenterol 85:350-355, 1990
    • (1990) Am J Gastroenterol , vol.85 , pp. 350-355
    • Steinberg, W.1
  • 10
    • 0025781243 scopus 로고
    • CA19-9 estimation in the assessment of pancreatic or biliary tract malignancy-What is the most efficient threshold value?
    • Welfare M, Tannar A: CA19-9 estimation in the assessment of pancreatic or biliary tract malignancy-What is the most efficient threshold value? Eur J Gastroenterol Hepatol 3:539-543, 1991
    • (1991) Eur J Gastroenterol Hepatol , vol.3 , pp. 539-543
    • Welfare, M.1    Tannar, A.2
  • 11
    • 0021345134 scopus 로고
    • Comparison of a new tumor marker, CA19-9, with a-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases
    • Jalanko H, Kuusela P, Roberts P, Sipponen P, Haglund C, Makela O: Comparison of a new tumor marker, CA19-9, with a-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases. J Clin Pathol 37:218-222, 1984
    • (1984) J Clin Pathol , vol.37 , pp. 218-222
    • Jalanko, H.1    Kuusela, P.2    Roberts, P.3    Sipponen, P.4    Haglund, C.5    Makela, O.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.